Cargando…
Retroviral gene therapy in Germany with a view on previous experience and future perspectives
Gene therapy can be used to restore cell function in monogenic disorders or to endow cells with new capabilities, such as improved killing of cancer cells, expression of suicide genes for controlled elimination of cell populations, or protection against chemotherapy or viral infection. While gene th...
Autores principales: | Morgan, Michael A., Galla, Melanie, Grez, Manuel, Fehse, Boris, Schambach, Axel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455336/ https://www.ncbi.nlm.nih.gov/pubmed/33753908 http://dx.doi.org/10.1038/s41434-021-00237-x |
Ejemplares similares
-
Non-integrating gamma-retroviral vectors as a versatile tool for transient zinc-finger nuclease delivery
por: Bobis-Wozowicz, Sylwia, et al.
Publicado: (2014) -
Analyzing the Genotoxicity of Retroviral Vectors in Hematopoietic Cell Gene Therapy
por: Biasco, Luca, et al.
Publicado: (2017) -
Gene therapy on the move
por: Kaufmann, Kerstin B, et al.
Publicado: (2013) -
Transient Retrovirus-Based CRISPR/Cas9 All-in-One Particles for Efficient, Targeted Gene Knockout
por: Knopp, Yvonne, et al.
Publicado: (2018) -
Efficient Pseudotyping of Different Retroviral Vectors Using a Novel, Codon-Optimized Gene for Chimeric GALV Envelope
por: Mirow, Manuela, et al.
Publicado: (2021)